Company profile for Assertio Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are Assertio — an assertive, energetic, and empathetic pharmaceutical company built around the mission of advancing patient care. Formerly known as Depomed, we have transformed our company with a current focus on three FDA-approved products in our core areas of neurology, orphan, and specialty medicines, as we continue to identify, license, and develop new products that offer enhanced options for patients who may be under...
We are Assertio — an assertive, energetic, and empathetic pharmaceutical company built around the mission of advancing patient care. Formerly known as Depomed, we have transformed our company with a current focus on three FDA-approved products in our core areas of neurology, orphan, and specialty medicines, as we continue to identify, license, and develop new products that offer enhanced options for patients who may be underserved by existing therapies.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
100 South Saunders Road, Suite 300 Lake Forest, IL 60045
Telephone
Telephone
224.419.7106
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

Global ChemShow

Not Confirmed

envelop Contact Supplier

Global ChemShow

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251110802048/en/Assertio-Reports-Third-Quarter-2025-Financial-Results

BUSINESS WIRE
10 Nov 2025
Assertio Announces Leadership Transition
Assertio Announces Leadership Transition

28 Oct 2025

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2025/10/28/3175550/0/en/Assertio-Announces-Leadership-Transition.html

GLOBENEWSWIRE
28 Oct 2025

https://www.globenewswire.com/news-release/2025/09/15/3150030/0/en/Assertio-Presents-First-Ever-Real-World-Study-Showing-Patient-Experience-with-SYMPAZAN-clobazam-Oral-Film-CIV.html

GLOBENEWSWIRE
15 Sep 2025

https://www.globenewswire.com/news-release/2025/09/10/3147667/0/en/Assertio-to-Present-New-Data-from-Real-World-Evidence-Study-of-SYMPAZAN-at-upcoming-150th-Annual-Meeting-of-the-American-Neurological-Association.html

GLOBENEWSWIRE
10 Sep 2025

https://www.globenewswire.com/news-release/2025/08/11/3131251/0/en/Assertio-Reports-Second-Quarter-2025-Financial-Results.html

GLOBENEWSWIRE
11 Aug 2025

https://www.globenewswire.com/news-release/2025/05/19/3084410/0/en/Assertio-to-Participate-in-the-Alliance-Global-Partners-Healthcare-Company-Showcase-on-May-21-2025.html

GLOBENEWSWIRE
19 May 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Contact Assertio Therapeutics and get a quotation

Assertio Therapeutics is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of Diclofenac bulk with DMF offered by Assertio Therapeutics

Find a price of Meloxicam bulk with DMF offered by Assertio Therapeutics

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty